Results 131 to 140 of about 28,532,237 (300)

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Appel à com - Colloque "Culture et contre-culture" - Univ. Paris Ouest Nanterre

open access: yes, 2011
COLLOQUE « CULTURE ET CONTRE-CULTURE : GENÈSES, PRATIQUES, CONCEPTUALISATIONS » Appel à communication Le Groupe d’analyse politique (GAP), le Centre d’études et de recherches sur l’espace germanophone (CEREG) et le Centre de recherches anglophones ...
gap
core  

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Management compliance attention, social performance and pay gap: Evidence from China.

open access: yesPLoS ONE
The pronounced pay gap prevalent in companies has raised critical concerns regarding organizational equity. This study investigates mechanisms to mitigate pay gap through the lens of management compliance attention, with the dual objectives of enhancing ...
Fei Han, Yong Jiang, Yanhan Sun
doaj   +1 more source

Computational Discovery of Dual-Target LDHA/BRD4 Inhibitors Targeting the Lactate–Kla–B7-H3 Immunosuppressive Axis Through AI-Driven Virtual Screening

open access: yesPharmaceuticals
Background/Objectives: Immune evasion remains a critical barrier to effective hepatocellular carcinoma (HCC) therapy. Lactate dehydrogenase A (LDHA) drives lactate accumulation and histone lysine lactylation (Kla), reshaping the immunosuppressive ...
Ruiqi Zhao   +5 more
doaj   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Sensitivity of dual waveguide probe complex permittivity and permeability measurement to probe lift-off error

open access: yes, 2009
The effect of lift-off (i.e., air-gap) error in dual waveguide probe material characterization measurements is presented here. The mitigation of this error using a two-layer dyadic Green's function analysis is also discussed. Experimental results for gap
M. W. Hyde   +3 more
core   +1 more source

Kil-ho LEE

open access: yes, 2011
 Kil-ho LEE Chercheur associé au Groupe d’Analyse Politique (GAP) Université Paris Ouest Nanterre La Défense E-mail : kilholee@u-paris10.fr Thèmes et orientations de recherche Sociologie des intellectuels, Sociologie des élites, Circulation ...
gap
core   +1 more source

Bridging the citizenship law implementation gap: a typology for comparative analysis

open access: yesComparative Migration Studies
While major advances have been made over the past years in comparing citizenship laws globally, most measures remain restricted to the law-on-the-books. Knowledge about the implementation of these laws remains limited.
Luuk van der Baaren
doaj   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy